Drugs (Full)

Stimulates alpha 1, beta 1, and beta 2 adrenergic receptors in dose related fashion.

• Bronchial Asthma,
• Acute Allergic Reaction,
• Anaphylaxis

0.3-0.5 mg SQ

Relaxes smooth muscles of the bronchial tree by stimulating adrenergic receptors of the sympathetic nervious system

• Asthma,
• Bronchospasm,
• COPD

2.5 mg Nebulized

Inhibits interaction of acetylcholine at cholinergic receptors on bronchial smooth muscle in the lung

Relief of bronchospasm due to COPD & obstructive airway disease

0.5 mg Nebulized

Prevents the actions of histamine by preventing histamines from reaching H1 receptor sites, and for reversing extrapyramidal reactions (EPS)

• Allergic Reactions,
• Anaphylaxis,
• Acute EPS

25-50 mg IVP, IM

Suppresses acute & chronic inflammation

• Anaphylaxis,
• Bronchodilator for unresponsive asthma

125 mg IVP

Binds to benzodiazepine receptors; enhances GABA effects.

To produce amnesia for RSI, Nasotracheal Intubation, & synchronized cardioversion

2.5 mg slow IVP over 2 minutes, may repeated every 2 minutes if necessary

Creates an ultra-short-acting sedative/hypnotic effect

• RSI,
• Conscious sedation for cardioversion

0.1-0.3 mg/kg IV over 30-60 seconds

Inhibits nerve impulse transmissions by binding the receptors for acetylcholine in the motor endplate. Depolarizing occurs which is evident with fasciculation.

To facilitate intubation of a live patient

1 mg/kg IVP over 10-30 seconds

Inhibits nerve impulse transmissions by binding the receptors for acetylcholine in the motor endplate

Induction or maintenance of paralysis after intubation to assist ventilations

• 0.1 mg/kg IV
• 0.01 mg/kg non-depolarizing dose

Binds to opiod receptors, producing analgesia & sedation. Increases peripheral venous capacitance & decreases venous return. Decreases myocardial oxygen demand.

• Moderate to severe pain,
• Pulmonary edema

2-4 mg slow IVP

Inhibits ascending pain pathways in CNS, increases pain threshold, alters pain perception.

Moderate to severe pain

1-2 mg IV given over 2-3 minutes

Inhibits ascending pain pathways in CNS, increases pain threshold, alters pain perception.

Moderate to severe pain

25-100 mcg IV

Inhibits loop of Henle. Sodium resorption.

• Pulmonary edema,
• Congestive heart failure

40 mg slow IVP - 10 mg/minute

Dilation of arterioles and veins in the periphery. Decreases workload of the heart and lowers myocardial oxygen demand.

• Ischemic chest pain,
• Congestive heart failure

0.4 mg SL

Inhibits platelet aggregation.

Chest pain associated with myocardial infarction

81-324 mg PO

Vasoconstriction and increase blood flow to the brain and heart during CPR.

Anytime CPR is being done

40 U IVP